185 related articles for article (PubMed ID: 28963461)
1. The identification of molecular target of (20S) ginsenoside Rh2 for its anti-cancer activity.
Wang YS; Lin Y; Li H; Li Y; Song Z; Jin YH
Sci Rep; 2017 Sep; 7(1):12408. PubMed ID: 28963461
[TBL] [Abstract][Full Text] [Related]
2. (20S) Ginsenoside Rh2 Inhibits STAT3/VEGF Signaling by Targeting Annexin A2.
Wang YS; Chen C; Zhang SY; Li Y; Jin YH
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502195
[TBL] [Abstract][Full Text] [Related]
3. (20S)G-Rh2 Inhibits NF-κB Regulated Epithelial-Mesenchymal Transition by Targeting Annexin A2.
Wang YS; Li H; Li Y; Zhang S; Jin YH
Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32244350
[TBL] [Abstract][Full Text] [Related]
4. Identification of natural compounds targeting Annexin A2 with an anti-cancer effect.
Wang YS; Li H; Li Y; Zhu H; Jin YH
Protein Cell; 2018 Jun; 9(6):568-579. PubMed ID: 29508276
[TBL] [Abstract][Full Text] [Related]
5. (20S) Ginsenoside Rh2 Exerts Its Anti-Tumor Effect by Disrupting the HSP90A-Cdc37 System in Human Liver Cancer Cells.
Chen C; Wang YS; Zhang ET; Li GA; Liu WY; Li Y; Jin YH
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884975
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside compound K inhibits nuclear factor-kappa B by targeting Annexin A2.
Wang YS; Zhu H; Li H; Li Y; Zhao B; Jin YH
J Ginseng Res; 2019 Jul; 43(3):452-459. PubMed ID: 31308817
[TBL] [Abstract][Full Text] [Related]
7. Antitumoral Activity of (20R)- and (20S)-Ginsenoside Rh2 on Transplanted Hepatocellular Carcinoma in Mice.
Lv Q; Rong N; Liu LJ; Xu XL; Liu JT; Jin FX; Wang CM
Planta Med; 2016 May; 82(8):705-11. PubMed ID: 27163230
[TBL] [Abstract][Full Text] [Related]
8. Pseudo-ginsenoside Rh2 Induces Protective Autophagy in Hepatocellular Carcinoma HepG2 Cells.
Zhang F; Xu H; Xia R; Yu P; Li Y; Yu X; Sui D
Recent Pat Anticancer Drug Discov; 2021; 16(4):521-532. PubMed ID: 34109916
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rh2 Targets EGFR by Up-Regulation of miR-491 to Enhance Anti-tumor Activity in Hepatitis B Virus-Related Hepatocellular Carcinoma.
Chen W; Qiu Y
Cell Biochem Biophys; 2015 Jun; 72(2):325-31. PubMed ID: 25561284
[TBL] [Abstract][Full Text] [Related]
10. (20S) Ginsenoside Rh2-Activated, Distinct Apoptosis Pathways in Highly and Poorly Differentiated Human Esophageal Cancer Cells.
Li H; Han C; Chen C; Han G; Li Y
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080369
[TBL] [Abstract][Full Text] [Related]
11. (20S)-Protopanaxadiol Ginsenosides Induced Cytotoxicity via Blockade of Autophagic Flux in HGC-27 Cells.
Han Q; Han L; Tie F; Wang Z; Ma C; Li J; Wang H; Li G
Chem Biodivers; 2020 Jul; 17(7):e2000187. PubMed ID: 32384197
[TBL] [Abstract][Full Text] [Related]
12. The interaction of serum albumin with ginsenoside Rh2 resulted in the downregulation of ginsenoside Rh2 cytotoxicity.
Lin Y; Li Y; Song ZG; Zhu H; Jin YH
J Ginseng Res; 2017 Jul; 41(3):330-338. PubMed ID: 28701874
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the NF-кB/p50/Bcl-3 complex in response to antiangiogenic therapy in a mouse model of metastatic renal cell carcinoma.
de Souza Braga M; da Silva Paiva KB; Foguer K; Barbosa Chaves KC; de Sá Lima L; Scavone C; Bellini MH
Biomed Pharmacother; 2014 Sep; 68(7):873-9. PubMed ID: 25113400
[TBL] [Abstract][Full Text] [Related]
14. Anticancer effect of 20(S)-ginsenoside Rh2 on HepG2 liver carcinoma cells: Activating GSK-3β and degrading β-catenin.
Shi Q; Shi X; Zuo G; Xiong W; Li H; Guo P; Wang F; Chen Y; Li J; Chen DL
Oncol Rep; 2016 Oct; 36(4):2059-70. PubMed ID: 27573179
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside 20(s)-Rh2 as potent natural histone deacetylase inhibitors suppressing the growth of human leukemia cells.
Liu ZH; Li J; Xia J; Jiang R; Zuo GW; Li XP; Chen Y; Xiong W; Chen DL
Chem Biol Interact; 2015 Dec; 242():227-34. PubMed ID: 26482938
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells.
Zhang C; Liu L; Yu Y; Chen B; Tang C; Li X
Mol Med Rep; 2012 May; 5(5):1295-8. PubMed ID: 22366885
[TBL] [Abstract][Full Text] [Related]
17. Production of the Rare Ginsenoside Rh2-MIX (20(
Song BK; Kim KM; Choi KD; Im WT
J Microbiol Biotechnol; 2017 Jul; 27(7):1233-1241. PubMed ID: 28478658
[TBL] [Abstract][Full Text] [Related]
18. [Effects of 20 (S) -ginsenoside Rh2 and 20 (R) -ginsenoside Rh2 on proliferation and apoptosis of human lung adenocarcinoma A549 cells].
Zhang C; Yu H; Hou J
Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(12):1670-4. PubMed ID: 22007558
[TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rh2 inhibits proliferation and induces apoptosis in human leukemia cells via TNF-α signaling pathway.
Huang J; Peng K; Wang L; Wen B; Zhou L; Luo T; Su M; Li J; Luo Z
Acta Biochim Biophys Sin (Shanghai); 2016 Aug; 48(8):750-5. PubMed ID: 27177748
[TBL] [Abstract][Full Text] [Related]
20. Key role of nuclear factor-κB in the cellular pharmacokinetics of adriamycin in MCF-7/Adr cells: the potential mechanism for synergy with 20(S)-ginsenoside Rh2.
Zhang J; Lu M; Zhou F; Sun H; Hao G; Wu X; Wang G
Drug Metab Dispos; 2012 Oct; 40(10):1900-8. PubMed ID: 22745335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
